Advances in Synthetic Immunology for Targeted Treatment of Systemic Autoimmune Diseases: Opportunities, Challenges, and Future Directions
Open Access
Abstract
Systemic autoimmune diseases (SAIDs) affect millions worldwide, presenting significant clinical challenges due to their complex pathogenesis and limited treatment options. Traditional immunosuppressive therapies, while effective, often lack precision, leading to significant side effects and inadequate disease control. Recent advances in synthetic immunology offer promising avenues for precise, targeted interventions in SAIDs. This review examines the latest innovations in synthetic immunology for treating autoimmune diseases, focusing on engineered immune cells, synthetic biologics, and gene-editing technologies. It explores the therapeutic potential of these approaches to modulate immune tolerance, reduce systemic inflammation, and enhance patient-specific treatment efficacy. However, despite these promising developments, challenges remain, including immune system complexity, safety concerns, and regulatory hurdles that may hinder clinical translation. This review aims to consolidate current advancements, address existing barriers, and outline potential future directions for synthetic immunology in autoimmune disease management, highlighting synthetic immunology’s role in transforming the therapeutic landscape for SAIDs.Keywords
This publication has 154 references indexed in Scilit:
- Dexamethasone Acetate‐Loaded PLGA Nanospheres Targeting Liver MacrophagesMacromolecular Bioscience, 2024
- Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 TrialArthritis & Rheumatology, 2023
- Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging TrialACR Open Rheumatology, 2022
- Gut Microbiome in Progressive Multiple SclerosisAnnals of Neurology, 2021
- Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to DateBioDrugs, 2020
- Myeloid Populations in Systemic Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2017
- Computational de novo design of antibodies binding to a peptide with high affinityBiotechnology and Bioengineering, 2017
- Toll-Like Receptor Pathways in Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2015
- Autoimmunity and inflammation: murine models and translational studiesMammalian Genome, 2011
- Use of synthetic peptides for the detection and quantification of autoantibodiesMolecular Biology Reports, 1992